PMID:18236465: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
/Volumes/r3/t3/ul/working/touchTables/touch_all_tables.php
imported>Wikientrybot
change PMID template to TableEdit version
Line 1: Line 1:
{{RightTOC}}
{{RightTOC}}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.115252.S52238f9a82e2d-->
<!--
******************************************************************************************
*
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
*
****************************************************************************************** -->
{|  id="S52238f9a82e2d"  class=" tableEdit PMID_info_table" 


<span style = 'font-size: large'> '''Vandenburgh, H, Shansky, J, Benesch-Lee, F, Barbata, V, Reid, J, Thorrez, L, Valentini, R and Crawford, G'''  (2008) Drug-screening platform based on the contractility of tissue-engineered muscle.''Muscle Nerve'' </span>
{|{{Prettytable}} align = 'center' width= '70%'
|-
|-
|{{TableHeadingColor}} |'''Abstract''' || A tissue-based approach to in vitro drug screening allows for determination of the cumulative positive and negative effects of a drug at the tissue rather than the cellular or subcellular level. Skeletal muscle myoblasts were tissue-engineered into three-dimensional muscle with parallel myofibers generating directed forces. When grown attached to two flexible microposts (muposts) acting as artificial tendons in a 96-well plate format, the miniature bioartificial muscles (mBAMs) generated tetanic (active) forces upon electrical stimulation measured with a novel image-based motion detection system. mBAM myofiber hypertrophy and active force increased in response to insulin-like growth factor 1. In contrast, mBAM deterioration and weakness was observed with a cholesterol-lowering statin. The results described in this study demonstrate the integration of tissue engineering and biomechanical testing into a single platform for the screening of compounds affecting muscle strength. Muscle Nerve, 2007.
!align=left  |Citation
</noinclude>
||
'''No author listed'''  (2008) Drug-screening platform based on the contractility of tissue-engineered muscle. ''Muscle Nerve'' '''37''':438-47
|-
!align=left  |Abstract
||
A tissue-based approach to in vitro drug screening allows for determination of the cumulative positive and negative effects of a drug at the tissue rather than the cellular or subcellular level. Skeletal muscle myoblasts were tissue-engineered into three-dimensional muscle with parallel myofibers generating directed forces. When grown attached to two flexible micro-posts (mu posts) acting as artificial tendons in a 96-well plate format, the miniature bioartificial muscles (mBAMs) generated tetanic (active) forces upon electrical stimulation measured with a novel image-based motion detection system. mBAM myofiber hypertrophy and active force increased in response to insulin-like growth factor 1. In contrast, mBAM deterioration and weakness was observed with a cholesterol-lowering statin. The results described in this study demonstrate the integration of tissue engineering and biomechanical testing into a single platform for the screening of compounds affecting muscle strength.
|-
!align=left  |Links
||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18236465 PubMed]
Online version:[http://dx.doi.org/10.1002/mus.20931 10.1002/mus.20931]
|-
|-
|{{TableHeadingColor}} nowrap |'''Links''' ||  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18236465 PubMed]
!align=left  |Keywords
||
Animals; Biological Assay/instrumentation; Biological Assay/methods; Cells, Cultured; Drug Evaluation, Preclinical/instrumentation; Drug Evaluation, Preclinical/methods; Electric Stimulation; Heptanoic Acids/pharmacology; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology; Insulin-Like Growth Factor I/pharmacology; Male; Mice; Mice, Inbred C3H; Muscle Contraction/drug effects; Muscular Atrophy/drug therapy; Muscular Atrophy/physiopathology; Myoblasts/cytology; Myoblasts/drug effects; Pyrroles/pharmacology; Tissue Engineering/instrumentation; Tissue Engineering/methods
 
|- class="tableEdit_footer"
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.115252.S52238f9a82e2d&page=115252&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> ||
|}
|}
 
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.115252.S52238f9a82e2d-->
==Significance {{HelpIcon|Help:Literature}} ==
==Significance {{HelpIcon|Help:Literature}} ==
{{LitSignificance}}
{{LitSignificance}}

Revision as of 19:03, 1 September 2013

Citation

No author listed (2008) Drug-screening platform based on the contractility of tissue-engineered muscle. Muscle Nerve 37:438-47

Abstract

A tissue-based approach to in vitro drug screening allows for determination of the cumulative positive and negative effects of a drug at the tissue rather than the cellular or subcellular level. Skeletal muscle myoblasts were tissue-engineered into three-dimensional muscle with parallel myofibers generating directed forces. When grown attached to two flexible micro-posts (mu posts) acting as artificial tendons in a 96-well plate format, the miniature bioartificial muscles (mBAMs) generated tetanic (active) forces upon electrical stimulation measured with a novel image-based motion detection system. mBAM myofiber hypertrophy and active force increased in response to insulin-like growth factor 1. In contrast, mBAM deterioration and weakness was observed with a cholesterol-lowering statin. The results described in this study demonstrate the integration of tissue engineering and biomechanical testing into a single platform for the screening of compounds affecting muscle strength.

Links

PubMed Online version:10.1002/mus.20931

Keywords

Animals; Biological Assay/instrumentation; Biological Assay/methods; Cells, Cultured; Drug Evaluation, Preclinical/instrumentation; Drug Evaluation, Preclinical/methods; Electric Stimulation; Heptanoic Acids/pharmacology; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology; Insulin-Like Growth Factor I/pharmacology; Male; Mice; Mice, Inbred C3H; Muscle Contraction/drug effects; Muscular Atrophy/drug therapy; Muscular Atrophy/physiopathology; Myoblasts/cytology; Myoblasts/drug effects; Pyrroles/pharmacology; Tissue Engineering/instrumentation; Tissue Engineering/methods

Significance

You can help EcoliWiki by summarizing why this paper is useful

Useful Materials and Methods

You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.

Annotations

Gene product Qualifier GO ID GO term name Evidence Code with/from Aspect Notes Status

EcoliWiki Links

Add links to pages that link here (e.g. gene, product, method pages)

References

See Help:References for how to manage references in EcoliWiki.